Skip to content

Effects of Indoor Air Pollution Intervention on Health Outcomes in Patients with Idiopathic Pulmonary Fibrosis

Measurement of indoor air pollution exposure and analysis of health effects in patients with idiopathic pulmonary fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010534
Enrollment
40
Registered
2025-05-26
Start date
2023-02-15
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : The intervention group will receive a structured behavioral program aimed at reducing indoor exposure to fine particulate matter (PM2.5) in patients with idiopathic pulmonary fibrosis (IP

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who meet the 2018 revised international diagnostic criteria for idiopathic pulmonary fibrosis (IPF), as defined by the American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society, and Latin American Thoracic Society. 2.Residents of Seoul or the metropolitan area. 3.Pulmonary function test (PFT) results showing: - Forced vital capacity (FVC) between 40% and 80% of the predicted value - Diffusing capacity for carbon monoxide (DLCO) between 30% and 80% of the predicted value

Exclusion criteria

Exclusion criteria: Interstitial lung disease with known causes (e.g., environmental exposures, connective tissue diseases, drug-induced) Age under 50 years Current smokers

Design outcomes

Primary

MeasureTime frame
Change in proportion of high indoor PM2.5 exposure (=10 µg/m³)

Secondary

MeasureTime frame
Changes in forced vital capacity;Changes in diffusing capacity for carbon monixide;Changes in quality of life;Changes in perception of air pollution

Countries

Korea, Republic of

Contacts

Public ContactHee-Young Yoon

Soon Chun Hyang University Hospital Seoul

bluecat-s@hanmail.net+82-2-709-9111

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026